GILEAD SCIENCES, INC.·4

Jul 2, 4:14 PM ET

O'Day Daniel Patrick 4

4 · GILEAD SCIENCES, INC. · Filed Jul 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Gilead (GILD) CEO Daniel O'Day Sells 15,000 Shares

What Happened Daniel Patrick O'Day, Chairman & CEO of Gilead Sciences (GILD), disposed of 15,000 shares on July 1, 2026 in two reported transactions. He sold 11,900 shares at $126.09 each for $1,500,467 and 3,100 shares at $127.08 each for $393,933, for total proceeds of approximately $1,894,400. These were sales (dispositions), not purchases.

Key Details

  • Transaction dates: July 1, 2026; Form 4 filed July 2, 2026 (timely filing).
  • Reported trades:
    • 11,900 shares @ $126.09 = $1,500,467
    • 3,100 shares @ $127.08 = $393,933
  • Total shares sold: 15,000; total proceeds ≈ $1,894,400.
  • Footnotes:
    • F1: Trades were made pursuant to a Rule 10b5-1 trading plan adopted Feb 25, 2026.
    • F2/F3: Reported sale-price ranges for the two blocks are $125.59–$126.55 and $126.595–$127.44; detailed per-price breakdown is available upon request.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Transaction type code: S = Sale (disposition).

Context Sales executed under a 10b5-1 plan are pre-arranged and typically indicate pre-planned dispositions rather than ad-hoc trading based on nonpublic information. For retail investors, such planned sales are common for executives to diversify or meet personal liquidity needs; they are not a direct, unambiguous signal about the company's near-term prospects.

Insider Transaction Report

Form 4
Period: 2026-07-01
O'Day Daniel Patrick
DirectorChairman & CEO
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-07-01$126.09/sh11,900$1,500,467610,233 total
  • Sale

    Common Stock

    [F1][F3]
    2026-07-01$127.08/sh3,100$393,933607,133 total
Footnotes (3)
  • [F1]The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
  • [F2]Sale prices for the transactions reported range from $125.59 to $126.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
  • [F3]Sale prices for the transactions reported range from $126.595 to $127.44. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Signature
/s/ Amy Kim by Power of Attorney for Daniel O'Day|2026-07-02

Documents

1 file
  • 4
    wk-form4_1783023256.xmlPrimary

    FORM 4